SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13D - General statement of acquisition of beneficial ownership:
SEC Accession No. 0001596770-16-000144
Filing Date
2016-08-26
Accepted
2016-08-26 16:09:57
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13D 8-26-16 schedule13d.htm SC 13D 239447
  Complete submission text file 0001596770-16-000144.txt   241185
Mailing Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404
Business Address 521 COTTONWOOD DRIVE, SUITE 100 MALPITAS CA 95035-7404 408-649-7370
Protagonist Therapeutics, Inc (Subject) CIK: 0001377121 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D | Act: 34 | File No.: 005-89601 | Film No.: 161854931
SIC: 2834 Pharmaceutical Preparations

Mailing Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204
Business Address 115 W WASHINGTON STREET SUITE 1680 SOUTH INDIANAPOLIS IN 46204 (317) 429-0140
Lilly Ventures Fund I LLC (Filed by) CIK: 0001575852 (see all company filings)

IRS No.: 264769290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D